Chicago, IL (PRWEB) February 28, 2013
OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will be exhibiting at the 2013 American Academy of Orthopedic Surgeons (AAOS). The meeting will take place March 20th through the 22nd in Chicago. The company is excited to celebrate major clinical milestones and increase the presence of the growing tourniquet of choice.
In 2012 OHK Medical Devices celebrated the 500,000 application of HemaClear®. Further, it celebrated the successful launch of HemaClear® in multiple countries including Australia, France and South Korea.
“We are very excited to showcase our tourniquet technology at the AAOS. The conference provides a unique opportunity to introduce surgeons to the first innovation in the field in over a century" said Omer Inbar, VP of Sales, OHK Medical Devices. Mr. Inbar added that “After a very strong year in 2012, we are off to a fantastic start in 2013 as HemaClear sales continue to take off. Our current expansion efforts combine creating a presence in new markets such as Latin America, Eastern Europe and Scandinavia and deepening our footprint in the existing markets in Europe and the US.”
OHK Medical Devices will be exhibiting in the main hall of the McCormick Center booth #1108. Surgeons and industry professionals are urged to come by the booth and learn why HemaClear® is quickly becoming the global tourniquet of choice.
HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the ma
Copyright©2012 Vocus, Inc.
All rights reserved